Oral News and Research

RSS

Lawmakers target fiscal cliff's provision aiding Amgen for elimination

The fiscal cliff legislation approved earlier this month excluded Amgen's Sensipar, which is used by kidney dialysis patients, from Medicare price controls for an additional two years.

28 Jan 2013

FDA accepts Genzyme’s LEMTRADA sBLA for review

Genzyme, a Sanofi Company, announced that the U.S. Food and Drug Administration (FDA) has accepted for review the company's supplemental Biologics License Application (sBLA) file seeking approval of LEMTRADA (alemtuzumab) for the treatment of relapsing multiple sclerosis (RMS).

28 Jan 2013

First Edition: January 25, 2013

Today's headlines include various state-level reports about how budget issues are impacting health policy decisions.

28 Jan 2013

Periodontal health influences stem cell transplant success

Periodontal infection can increase the risk for developing bacteremia during the neutropenic phase of allogeneic hematopoietic stem cell transplantation, research suggests.

25 Jan 2013

Indian company plans to make lower-cost injectable polio vaccine

Serum Institute of India Ltd., the world's largest vaccine manufacturer, plans to "slash the price of polio immunization and introduce shots for diarrhea and pneumonia, undercutting Pfizer Inc. and GlaxoSmithKline Plc.," Bloomberg Businessweek reports.

24 Jan 2013

Tofacitinib improves disease activity and inhibits progression of joint damage in RA patients

A Phase 3 clinical trial demonstrates that tofacitinib improves disease activity and inhibits progression of joint damage in rheumatoid arthritis (RA) patients who did not respond to methotrexate (MTX).

24 Jan 2013

Roundup: Ariz. Gov. proposing hospital tax for Medicaid expansion as Nev. ponders options; Vt. hospitals form ACO

Ariz. Gov. Jan Brewer, who has become something of a conservative icon for her aggressive opposition to Mr. Obama's policies, surprised many Legislature watchers at her State of the State address last week by saying she wanted to expand the state's Medicaid program to include anyone who makes up to 133 percent of the federal poverty level, or $14,856 for an individual.

23 Jan 2013

Oral supplement of live R. Opacus may help pigs stay healthy during weaning

A common type of bacteria may help pigs stay healthy during weaning. In a study of 36 weanling-age pigs, researchers found that a dose of lipid-producing Rhodococcus opacus bacteria increased circulating triglycerides. Triglycerides are a crucial source of energy for the immune system.

23 Jan 2013

STA announces results from ABRAXANE plus gemcitabine phase III trial on pancreatic cancer

Australian biopharmaceutical company Specialised Therapeutics Australia announces that a phase III clinical trial of world leading breast cancer drug ABRAXANE (nanoparticle albumin-bound paclitaxel) in combination with current standard of care gemcitabine in patients with advanced pancreatic cancer has demonstrated substantially improved survival times, with double the number of patients surviving two years.

23 Jan 2013

FDA approves Ampio’s IND for Optina for treatment of diabetic macular edema

Ampio Pharmaceuticals, Inc. announced today that the FDA has accepted the Company's IND for Optina™ for the treatment of diabetic macular edema (DME). Ampio plans to commence enrollment in a clinical trial in the first quarter of 2013. The FDA granted Optina™ 505(b)(2) status in July, 2012. Drugs designated under this pathway can be approved on a single trial.

22 Jan 2013

Itch-specific nerve cells: an interview with Associate Professor Xinzhong Dong

Itch was actually defined by a German physician more than 350 years ago. His name was Samuel Hafenreffer. He defined itch as an unpleasant sensation that makes people want to scratch. You probably think this is a very simple definition but itch is really a very complex sensory modality.

21 Jan 2013

G-CON completes delivery and installation of POD system in PaxVax's GMP production facility

G-CON today announced the completed delivery and installation of the ground-breaking POD system in PaxVax's licensed GMP production facility based in San Diego, California where PaxVax manufactures innovative and socially responsible oral vaccines against infectious diseases.

19 Jan 2013

FDA approves Allergan’s BOTOX to treat overactive bladder

Allergan, Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved BOTOX (onabotulinumtoxinA) for the treatment of overactive bladder (OAB) with symptoms of urge urinary incontinence, urgency and frequency in adults who have had an inadequate response to or are intolerant of an anticholinergic medication.

19 Jan 2013

Researchers identify signaling pathway used by malarial parasites to destroy host cells

One of the most insidious ways that parasitic diseases such as malaria and toxoplasmosis wreak their havoc is by hijacking their host's natural cellular processes, turning self against self.

18 Jan 2013

Enrollment complete in GlycoMimetics’ GMI-1070 Phase 2 study for sickle cell disease

GlycoMimetics, Inc. (GMI), a clinical-stage biotechnology company researching a new class of glycobiology-based therapies for a broad range of diseases, today announced that it has completed enrolling patients in its Phase 2 study of GMI-1070, its lead investigational drug candidate.

18 Jan 2013

Children's Oakland recruits patients for deferiprone clinical trial to treat PKAN

A groundbreaking, international clinical trial of an iron chelation drug, deferiprone, to treat the rare and devastating neurodegenerative disease, pantothenate kinase-associated neurodegeneration (PKAN), began last month at the trial's only North American site, Children's Hospital & Research Center Oakland.

17 Jan 2013

SyNAPSe® Trial by BHR Pharma deemed to have no safety issues according to DSMB

BHR Pharma, LLC announced today that the SyNAPSe® Trial's independent Data and Safety Monitoring Board (DSMB) evaluated safety data from 803 randomized patients and determined that no issues exist; therefore, the trial may continue towards its intended completion.

17 Jan 2013

TMD pain might reflect physical manifestation of anxiety or depression

There is an ongoing debate about the role of psychological disorder symptoms as risk factors for temporomandibular joint (TMJ) pain. Previous studies have associated depression and TMJ pain but large scale studies have not been performed.

17 Jan 2013

WHO reports unprecedented progress against 17 neglected tropical diseases

WHO reports unprecedented progress against 17 neglected tropical diseases, thanks to a new global strategy, a regular supply of quality assured, cost-effective medicines and support from global partners.

17 Jan 2013

India marks two years since last diagnosed polio case

On January 13, India "completed two years since the last case of the crippling disease was reported ... a huge achievement for a country that as recently as 2009 reported 741 cases of polio -- more than any other country in the world, and almost half of cases reported globally that year," the Wall Street Journal's "India Real Time" blog reports.

16 Jan 2013

Oral News and Research

Lawmakers target fiscal cliff's provision aiding Amgen for elimination

FDA accepts Genzyme’s LEMTRADA sBLA for review

First Edition: January 25, 2013

Periodontal health influences stem cell transplant success

Indian company plans to make lower-cost injectable polio vaccine

Tofacitinib improves disease activity and inhibits progression of joint damage in RA patients

Roundup: Ariz. Gov. proposing hospital tax for Medicaid expansion as Nev. ponders options; Vt. hospitals form ACO

Oral supplement of live R. Opacus may help pigs stay healthy during weaning

STA announces results from ABRAXANE plus gemcitabine phase III trial on pancreatic cancer

FDA approves Ampio’s IND for Optina for treatment of diabetic macular edema

Itch-specific nerve cells: an interview with Associate Professor Xinzhong Dong

G-CON completes delivery and installation of POD system in PaxVax's GMP production facility

FDA approves Allergan’s BOTOX to treat overactive bladder

Researchers identify signaling pathway used by malarial parasites to destroy host cells

Enrollment complete in GlycoMimetics’ GMI-1070 Phase 2 study for sickle cell disease

Children's Oakland recruits patients for deferiprone clinical trial to treat PKAN

SyNAPSe® Trial by BHR Pharma deemed to have no safety issues according to DSMB

TMD pain might reflect physical manifestation of anxiety or depression

WHO reports unprecedented progress against 17 neglected tropical diseases

India marks two years since last diagnosed polio case

Advancing Neuroscience Research Through Collaboration and Patient-Centered Innovation

The impact of vibration on microscopy

How Omics Technologies Are Transforming Biological Research and Drug Discovery

Latest News